C4 Therapeutics (CCCC) Current Assets: 2019-2025
Historic Current Assets for C4 Therapeutics (CCCC) over the last 5 years, with Sep 2025 value amounting to $206.9 million.
- C4 Therapeutics' Current Assets fell 24.29% to $206.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $206.9 million, marking a year-over-year decrease of 24.29%. This contributed to the annual value of $257.8 million for FY2024, which is 4.95% down from last year.
- Per C4 Therapeutics' latest filing, its Current Assets stood at $206.9 million for Q3 2025, which was down 7.95% from $224.7 million recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Current Assets ranged from a high of $477.6 million in Q2 2021 and a low of $206.9 million during Q3 2025.
- Over the past 3 years, C4 Therapeutics' median Current Assets value was $271.2 million (recorded in 2023), while the average stood at $254.4 million.
- As far as peak fluctuations go, C4 Therapeutics' Current Assets spiked by 97.34% in 2021, and later slumped by 33.34% in 2022.
- Over the past 5 years, C4 Therapeutics' Current Assets (Quarterly) stood at $325.7 million in 2021, then declined by 11.71% to $287.6 million in 2022, then dropped by 5.69% to $271.2 million in 2023, then declined by 4.95% to $257.8 million in 2024, then fell by 24.29% to $206.9 million in 2025.
- Its last three reported values are $206.9 million in Q3 2025, $224.7 million for Q2 2025, and $232.5 million during Q1 2025.